Literature DB >> 15521029

Hepatitis C: it's a long way to new therapy, it's a long way to go...

Jean-Michel Pawlotsky.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15521029     DOI： 10.1053/j.gastro.2004.09.059

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  2 in total

1.  Recombinant interferon-Beta-1alpha plus ribavirin for the treatment of chronic HCV infection: a prospective, randomized, comparative pilot study.

Authors:  Sang Hoon Ahn; Hyun Woong Lee; Yong Soo Kim; Ja Kyung Kim; Kwang-Hyub Han; Chae Yoon Chon; Young Myoung Moon
Journal:  Gut Liver       Date:  2009-03-31       Impact factor: 4.519

2.  Preclinical characteristics of the hepatitis C virus NS3/4A protease inhibitor ITMN-191 (R7227).

Authors:  Scott D Seiwert; Steven W Andrews; Yutong Jiang; Vladimir Serebryany; Hua Tan; Karl Kossen; P T Ravi Rajagopalan; Shawn Misialek; Sarah K Stevens; Antitsa Stoycheva; Jin Hong; Sharlene R Lim; Xiaoli Qin; Robert Rieger; Kevin R Condroski; Hailong Zhang; Mary Geck Do; Christine Lemieux; Gary P Hingorani; Dylan P Hartley; John A Josey; Lin Pan; Leonid Beigelman; Lawrence M Blatt
Journal:  Antimicrob Agents Chemother       Date:  2008-09-29       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.